AzTrials
AzTrials

Low Birth WeightEtudeTKNCT00531492

Efficacy of Continuous Skin to Skin Care (Technique Kangaroo: TK) After Birth for Low Birth Weight (LBW) Infants and Their Mothers in Developing Countries

A study testing TK as soon as possible within 24 hours after birth and Conventional care in people with Low Birth Weight, run by Foundation for Advanced Studies on International Development at 1 site in Madagascar.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to examine the efficacy of Technique Kangourou (TK) between low birth weight (LBW) infants and their mothers started as soon as possible within 24 hours after birth in developing country. Read more about this study

Who is it for?
Ages Up to 24 hours
Conditions the study is for
Low Birth Weight
What is being tested?
TK as soon as possible within 24 hours after birth and Conventional care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
73 participants
Where
1 siteMadagascar
Study dates
Aug 2007to Mar 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 24 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Birth weight (BW) < 2500g
  • Delivery at maternity of CHUM (Birth < 24 hours)
  • Without serious congenital malformation
  • Sat O2 >=95%, HR > 100 / min, RR < 60 / min, Capillary refilling time < 3 sec
  • The mother and the family are motivated to practice TK.
  • The mother and the family available to practise TK should be healthy.

Who cannot join

  • Apnea of prematurity >20 sec
  • With intravenous infusion

Trial locations and contacts

1 site in 1 country.

Madagascar1 site
  • University Hospital Center of Mahajanga (Centre Hospitalier Universitaire de Mahajanga: CHUM),

    Mahajanga, Mahajanga

Other trials in Madagascar

About this study

Official title: Randomized Controlled Trial of Continuous Skin to Skin Care (Technique Kangourou: TK) for Low Birth Weight (LBW) Infants and Their Mothers at University Hospital Center of Mahajanga (Centre Hospitalier Universitaire de Mahajanga: CHUM), Madagascar

The purpose of this study is to examine the efficacy of Technique Kangourou (TK) between low birth weight (LBW) infants and their mothers started as soon as possible within 24 hours after birth in developing country.

For the purpose of this study, TK is defined as skin-to-skin direct and continuous (24 hours) contact between LBW infants and their mothers or any other people who substitute mothers.

Being tested
TK as soon as possible within 24 hours after birth, Conventional care
Keywords
Maternal and child health, Developing country, Skin to skin care, Newly born low birth weight infants and their mothers, (Delivery at University Hospital Center, Mahajanga, Madagascar)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TK as soon as possible within 24 hours after birthBehavioural

    Start TK as soon as possible within 24 hours after birth

  • Conventional careOther

    Start conventional care (At first use incubator, and start TK when the infants and mother are completely settled and ready)

Study groups in NCT00531492
Study groupRoleWhat they receive
AExperimentalNot described
Receives: Behavioral: TK as soon as possible within 24 hours after birth
BActive comparatorNot described
Receives: Other: Conventional care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality within 28 days after birth

    Measured: within 28 days after birth

Secondary outcomes (15)
  1. Mobility within 28 days after birth

    Measured: within 28 days after birth

  2. Mortality and Mobility within 28 days after birth

    Measured: within 28 days after birth

  3. Difference of (Baby's) loss in weight within 2 days

    Measured: within 2 days

  4. Difference of (Baby's) Body weight of 14th day after birth

    Measured: 14th day after birth

  5. Difference of (Baby's) Body weight of 28th day after birth

    Measured: 28th day after birth

  6. Incidence of hypothermia during hospitalisation and (or) during outpatient department (lower than 35.5℃)

    Measured: Within 28 days after birth

  7. Incidence of bradycardia or tachycardia during hospitalisation (HR <100, or>180 /min)

    Measured: within 28 days after birth

  8. Incidence of apnea during hospitalisation (> 20 sec)

    Measured: within 28 days after birth

  9. Incidence of desaturation during hospitalisation ( <87%)

    Measured: within 28 days after birth

  10. Length of hospitalisation

    Measured: within 28 days after birth

  11. Discharge within 7days after birth

    Measured: within 7days after birth

  12. Mobility within 6 months or 1 year after birth

    Measured: within 6 months or 1 year

  13. Mortality and Morbility within 6 months or 1 year after birth

    Measured: within 6 months or 1 year

  14. Mortality within 6 months or 1 year after birth

    Measured: within 6 months or 1 year

  15. Incidence of hyperthermia during hospitalisation and (or) outpatient department (upper than 37.5℃)

    Measured: Within 28 days after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2007 (estimated)
  2. Study startAug 2007
  3. Primary completionSep 2008
  4. Study completionMar 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00531492
Sponsor's protocol ID
FASID-06-CE-56
Acronym
EtudeTK
Status last verified
Dec 2011
First submitted
17 Sep 2007
Last updated
12 Dec 2011
Results posted
No
Data monitoring committee
No

Publications

  • Nagai S, Andrianarimanana D, Rabesandratana N, Yonemoto N, Nakayama T, Mori R. Earlier versus later continuous Kangaroo Mother Care (KMC) for stable low-birth-weight infants: a randomized controlled trial. Acta Paediatr. 2010 Jun;99(6):827-35. doi: 10.1111/j.1651-2227.2009.01676.x. Epub 2010 Jan 27.

    PubMed 20121708
  • Nagai S, Yonemoto N, Rabesandratana N, Andrianarimanana D, Nakayama T, Mori R. Long-term effects of earlier initiated continuous Kangaroo Mother Care (KMC) for low-birth-weight (LBW) infants in Madagascar. Acta Paediatr. 2011 Dec;100(12):e241-7. doi: 10.1111/j.1651-2227.2011.02372.x. Epub 2011 Jun 23.

    PubMed 21635363

Questions about this trial

What is this clinical trial studying?

A study testing TK as soon as possible within 24 hours after birth and Conventional care in people with Low Birth Weight, run by Foundation for Advanced Studies on International Development at 1 site in Madagascar.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Madagascar. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality within 28 days after birth (time frame: within 28 days after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00531492, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in